Researchers have developed BigRNA, a groundbreaking deep learning model capable of predicting RNA behavior, including tissue-specific expression and splicing, directly from genomic DNA sequences. The model excels in identifying pathogenic variants and could be a game-changer in the development of personalized RNA-based therapies for treating genetic diseases.
Amarin lays off US salesforce, names new CEO in shakeup
The new crew in charge at Amarin has outlined their plans to turn things around — and it involves a sweeping reorg. Amarin will cut